SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001372514-23-000120
Filing Date
2023-08-10
Accepted
2023-08-10 17:23:41
Documents
5
Period of Report
2023-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1691702609.html 3  
1 FORM 3 wk-form3_1691702609.xml 3 1663
2 EX-24.1 exhibit241_carminestengo.htm EX-24.1 6797
3 exhibit241_carminestengo001.jpg GRAPHIC 250701
4 exhibit241_carminestengo002.jpg GRAPHIC 129591
5 exhibit241_carminestengo003.jpg GRAPHIC 32553
  Complete submission text file 0001372514-23-000120.txt   578842
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Stengone Carmine N. (Reporting) CIK: 0001861519 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 231160759